Long-term outcomes comparing surgery to embolization-ablation for treatment of solitary HCC <7 cm

Eldad Elnekave, Joseph P. Erinjeri, Karen T. Brown, Raymond H. Thornton, Elena N. Petre, Majid Maybody, Mary Maluccio, Meier Hsu, Constantinos T. Sofocleous, George I. Getrajdman, Lynn A. Brody, Stephen B. Solomon, William Alago, Yuman Fong, William R. Jarnagin, Anne M. Covey

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Background: Resection has been the standard of care for patients with solitary hepatocellular carcinoma (HCC). Transarterial embolization and percutaneous ablation are alternative therapies often reserved for suboptimal surgical candidates. Here we compare long-term outcomes of patients with solitary HCC treated with resection versus combined embo-ablation. Methods: We previously reported a retrospective comparison of resection and embo-ablation in 73 patients with solitary HCC <7 cm after a median follow-up of 23 months. This study represents long-term updated follow-up over a median of 134 months. Results: There was no difference in survival among Okuda I patients who underwent resection versus embo-ablation (66 vs 58 months, p =.39). There was no difference between the groups in the rate of distant intrahepatic (p =.35) or metastatic progression (p =.48). Surgical patients experienced more complications (p =.004), longer hospitalizations (p <.001), and were more likely to require hospital readmission within 30 days of discharge (p =.03). Conclusion: Over a median follow up of more than 10 years, we found no significant difference in overall survival of Okuda 1 patients with solitary HCC <7 cm who underwent surgical resection versus embo-ablation. Our data suggest that there may be a greater role for primary embo-ablation in the treatment of potentially resectable solitary HCC.

Original languageEnglish
Pages (from-to)2881-2886
Number of pages6
JournalAnnals of Surgical Oncology
Volume20
Issue number9
DOIs
StatePublished - Sep 2013

Fingerprint

Hepatocellular Carcinoma
Therapeutics
Patient Readmission
Survival
Standard of Care
Complementary Therapies
Hospitalization

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this

Elnekave, E., Erinjeri, J. P., Brown, K. T., Thornton, R. H., Petre, E. N., Maybody, M., ... Covey, A. M. (2013). Long-term outcomes comparing surgery to embolization-ablation for treatment of solitary HCC <7 cm. Annals of Surgical Oncology, 20(9), 2881-2886. https://doi.org/10.1245/s10434-013-2961-2

Long-term outcomes comparing surgery to embolization-ablation for treatment of solitary HCC <7 cm. / Elnekave, Eldad; Erinjeri, Joseph P.; Brown, Karen T.; Thornton, Raymond H.; Petre, Elena N.; Maybody, Majid; Maluccio, Mary; Hsu, Meier; Sofocleous, Constantinos T.; Getrajdman, George I.; Brody, Lynn A.; Solomon, Stephen B.; Alago, William; Fong, Yuman; Jarnagin, William R.; Covey, Anne M.

In: Annals of Surgical Oncology, Vol. 20, No. 9, 09.2013, p. 2881-2886.

Research output: Contribution to journalArticle

Elnekave, E, Erinjeri, JP, Brown, KT, Thornton, RH, Petre, EN, Maybody, M, Maluccio, M, Hsu, M, Sofocleous, CT, Getrajdman, GI, Brody, LA, Solomon, SB, Alago, W, Fong, Y, Jarnagin, WR & Covey, AM 2013, 'Long-term outcomes comparing surgery to embolization-ablation for treatment of solitary HCC <7 cm', Annals of Surgical Oncology, vol. 20, no. 9, pp. 2881-2886. https://doi.org/10.1245/s10434-013-2961-2
Elnekave, Eldad ; Erinjeri, Joseph P. ; Brown, Karen T. ; Thornton, Raymond H. ; Petre, Elena N. ; Maybody, Majid ; Maluccio, Mary ; Hsu, Meier ; Sofocleous, Constantinos T. ; Getrajdman, George I. ; Brody, Lynn A. ; Solomon, Stephen B. ; Alago, William ; Fong, Yuman ; Jarnagin, William R. ; Covey, Anne M. / Long-term outcomes comparing surgery to embolization-ablation for treatment of solitary HCC <7 cm. In: Annals of Surgical Oncology. 2013 ; Vol. 20, No. 9. pp. 2881-2886.
@article{6a604ca14c464f09baea84564cd773e9,
title = "Long-term outcomes comparing surgery to embolization-ablation for treatment of solitary HCC <7 cm",
abstract = "Background: Resection has been the standard of care for patients with solitary hepatocellular carcinoma (HCC). Transarterial embolization and percutaneous ablation are alternative therapies often reserved for suboptimal surgical candidates. Here we compare long-term outcomes of patients with solitary HCC treated with resection versus combined embo-ablation. Methods: We previously reported a retrospective comparison of resection and embo-ablation in 73 patients with solitary HCC <7 cm after a median follow-up of 23 months. This study represents long-term updated follow-up over a median of 134 months. Results: There was no difference in survival among Okuda I patients who underwent resection versus embo-ablation (66 vs 58 months, p =.39). There was no difference between the groups in the rate of distant intrahepatic (p =.35) or metastatic progression (p =.48). Surgical patients experienced more complications (p =.004), longer hospitalizations (p <.001), and were more likely to require hospital readmission within 30 days of discharge (p =.03). Conclusion: Over a median follow up of more than 10 years, we found no significant difference in overall survival of Okuda 1 patients with solitary HCC <7 cm who underwent surgical resection versus embo-ablation. Our data suggest that there may be a greater role for primary embo-ablation in the treatment of potentially resectable solitary HCC.",
author = "Eldad Elnekave and Erinjeri, {Joseph P.} and Brown, {Karen T.} and Thornton, {Raymond H.} and Petre, {Elena N.} and Majid Maybody and Mary Maluccio and Meier Hsu and Sofocleous, {Constantinos T.} and Getrajdman, {George I.} and Brody, {Lynn A.} and Solomon, {Stephen B.} and William Alago and Yuman Fong and Jarnagin, {William R.} and Covey, {Anne M.}",
year = "2013",
month = "9",
doi = "10.1245/s10434-013-2961-2",
language = "English",
volume = "20",
pages = "2881--2886",
journal = "Annals of Surgical Oncology",
issn = "1068-9265",
publisher = "Springer New York",
number = "9",

}

TY - JOUR

T1 - Long-term outcomes comparing surgery to embolization-ablation for treatment of solitary HCC <7 cm

AU - Elnekave, Eldad

AU - Erinjeri, Joseph P.

AU - Brown, Karen T.

AU - Thornton, Raymond H.

AU - Petre, Elena N.

AU - Maybody, Majid

AU - Maluccio, Mary

AU - Hsu, Meier

AU - Sofocleous, Constantinos T.

AU - Getrajdman, George I.

AU - Brody, Lynn A.

AU - Solomon, Stephen B.

AU - Alago, William

AU - Fong, Yuman

AU - Jarnagin, William R.

AU - Covey, Anne M.

PY - 2013/9

Y1 - 2013/9

N2 - Background: Resection has been the standard of care for patients with solitary hepatocellular carcinoma (HCC). Transarterial embolization and percutaneous ablation are alternative therapies often reserved for suboptimal surgical candidates. Here we compare long-term outcomes of patients with solitary HCC treated with resection versus combined embo-ablation. Methods: We previously reported a retrospective comparison of resection and embo-ablation in 73 patients with solitary HCC <7 cm after a median follow-up of 23 months. This study represents long-term updated follow-up over a median of 134 months. Results: There was no difference in survival among Okuda I patients who underwent resection versus embo-ablation (66 vs 58 months, p =.39). There was no difference between the groups in the rate of distant intrahepatic (p =.35) or metastatic progression (p =.48). Surgical patients experienced more complications (p =.004), longer hospitalizations (p <.001), and were more likely to require hospital readmission within 30 days of discharge (p =.03). Conclusion: Over a median follow up of more than 10 years, we found no significant difference in overall survival of Okuda 1 patients with solitary HCC <7 cm who underwent surgical resection versus embo-ablation. Our data suggest that there may be a greater role for primary embo-ablation in the treatment of potentially resectable solitary HCC.

AB - Background: Resection has been the standard of care for patients with solitary hepatocellular carcinoma (HCC). Transarterial embolization and percutaneous ablation are alternative therapies often reserved for suboptimal surgical candidates. Here we compare long-term outcomes of patients with solitary HCC treated with resection versus combined embo-ablation. Methods: We previously reported a retrospective comparison of resection and embo-ablation in 73 patients with solitary HCC <7 cm after a median follow-up of 23 months. This study represents long-term updated follow-up over a median of 134 months. Results: There was no difference in survival among Okuda I patients who underwent resection versus embo-ablation (66 vs 58 months, p =.39). There was no difference between the groups in the rate of distant intrahepatic (p =.35) or metastatic progression (p =.48). Surgical patients experienced more complications (p =.004), longer hospitalizations (p <.001), and were more likely to require hospital readmission within 30 days of discharge (p =.03). Conclusion: Over a median follow up of more than 10 years, we found no significant difference in overall survival of Okuda 1 patients with solitary HCC <7 cm who underwent surgical resection versus embo-ablation. Our data suggest that there may be a greater role for primary embo-ablation in the treatment of potentially resectable solitary HCC.

UR - http://www.scopus.com/inward/record.url?scp=84881477446&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84881477446&partnerID=8YFLogxK

U2 - 10.1245/s10434-013-2961-2

DO - 10.1245/s10434-013-2961-2

M3 - Article

VL - 20

SP - 2881

EP - 2886

JO - Annals of Surgical Oncology

JF - Annals of Surgical Oncology

SN - 1068-9265

IS - 9

ER -